HEALTHEQUITY, INC. 8K

HealthEquity, Inc. reported strong second quarter 2026 results with higher revenue, profits, HSA assets, and share repurchases, and raised its fiscal 2027 financial guidance.

HealthEquity, Inc. filed a Form 8-K to furnish its earnings press release reporting financial results for the second quarter ended July 31, 2026, highlighting 8% year-over-year revenue growth to $350.7 million, a 10% increase in net income to $65.6 million (net margin of 19%), an 11% increase in Adjusted EBITDA to $167.0 million (48% margin), and 14% growth in total HSA assets to $37.9 billion. The company noted record HSA accounts of 10.7 million, strong growth in HSAs with investments, and the repurchase of 1.2 million shares for $108.1 million under its ongoing stock repurchase program. Management raised fiscal year 2027 guidance for revenue to a range of $1.411–$1.421 billion, net income to $242–$248 million (GAAP EPS of $2.88–$2.96), non-GAAP net income to $392–$398 million (non-GAAP EPS of $4.66–$4.73), and Adjusted EBITDA to $628–$636 million, and announced details of an investor conference call to discuss these results. The release also provides detailed GAAP financial statements, reconciliations to non-GAAP measures, and updated commentary on key business metrics and risk factors.

Filing Facts

CIK

1428336

Ticker

-

Form

8K

Source Type

sec

Accession

0001428336-26-000040

Alert Tier

7